Cloherty and Stark`s Manual of Neonatal Care-9판

1 Fetal Assessment and Prenatal Diagnosis

I. GESTATIONAL AGE ASSESSMENT
II. PRENATAL DIAGNOSIS OF FETAL DISEASE
III. FETAL SIZE AND GROWTH-RATE ABNORMALITIES
IV. FUNCTIONAL MATURITY OF THE LUNGS
V. ASSESSMENT OF FETAL WELL-BEING

2 Maternal Diabetes Mellitus

I. CLASSIFICATION OF DIABETES IN PREGNANCY
II. EPIDEMIOLOGY
III. COMPLICATIONS
IV. PRECONCEPTION MANAGEMENT
V. ANTEPARTUM MANAGEMENT
VI. INTRAPARTUM AND POSTPARTUM MANAGEMENT

3 Preeclampsia and Related Hypertensive Conditions of Pregnancy

I. CATEGORIES OF PREGNANCY-ASSOCIATED HYPERTENSIVE DISORDERS
II. INCIDENCE AND EPIDEMIOLOGY
III. DIAGNOSIS
IV. COMPLICATIONS
V. CONSIDERATIONS IN MANAGEMENT
VI. CLINICAL MANAGEMENT OF GESTATIONAL HYPERTENSION AND PREECLAMPSIA WITHOUT SEVERE FEATURES
VII. MANAGEMENT OF PREECLAMPSIA WITH SEVERE FEATURES
VIII. MANAGEMENT OF ECLAMPSIA
IX. POSTPARTUM PREECLAMPSIA
X. RECURRENCE RISK
XI. LONG-TERM CARDIOVASCULAR RISK
XII. PROPOSED TREATMENTS
XIII. IMPLICATIONS FOR THE NEWBORN

4 Resuscitation in the Delivery Room

I. GENERAL PRINCIPLES
II. PREPARATION
III. DURING DELIVERY
IV. SPECIAL SITUATIONS
V. MONITORING RESUSCITATION
VI. POSTRESUSCITATIVE CARE
VII. WITHHOLDING OR DISCONTINUING RESUSCITATION
VIII. TEAMWORK DURING NEONATAL RESUSCITATION

5 Nonimmune Hydrops Fetalis

I. DEFINITION
II. INCIDENCE
III. ETIOLOGY
IV. PATHOPHYSIOLOGY
V. EVALUATION
VI. PRENATAL TREATMENT
VII. MATERNAL COMPLICATIONS OF FETAL HYDROPS
VIII. DELIVERY CONSIDERATIONS
IX. NEONATAL MANAGEMENT OF FETAL HYDROPS

6 Birth Trauma

I. BACKGROUND
II. TYPES OF BIRTH TRAUMA

7 The High-Risk Newborn: Anticipation, Evaluation, Management, and Outcome

I. HIGH-RISK NEWBORNS
II. GESTATIONAL AGE (GA) AND BIRTH WEIGHT CLASSIFICATION
III. PRETERM BIRTH
IV. POSTTERM INFANTS
V. SGA
VI. LGA

8 Assessment of the Newborn History and Physical Examination of the Newborn

I. HISTORY
II. ROUTINE PHYSICAL EXAMINATION OF THE NEONATE

9 Care of the Well Newborn
I. ADMISSION TO THE NEWBORN NURSERY
II. TRANSITIONAL CARE
III. ROUTINE CARE
IV. ROUTINE MEDICATIONS
V. SCREENING
VI. ROUTINE ASSESSMENTS
VII. FAMILY AND SOCIAL ISSUES
VIII. FEEDINGS
IX. NEWBORN CIRCUMCISION
X. DISCHARGE PREPARATION
XI. FOLLOW-UP

10 Genetic Issues Presenting in the Nursery
I. GENERAL PRINCIPLES
II. INCIDENCE
III. ETIOLOGY
IV. APPROACH TO THE INFANT WITH A CONGENITAL MALFORMATION OR OTHER SUSPECTED GENETIC DISORDER

11 Multiple Births
I. CLASSIFICATION
II. EPIDEMIOLOGY
III. ETIOLOGY
IV. DIAGNOSIS
V. PRENATAL SCREENING AND DIAGNOSIS
VI. MATERNAL COMPLICATIONS
VII. FETAL AND NEONATAL COMPLICATIONS
VIII. OUTCOMES

12 Maternal Substance Use, Infant Exposure, and Neonatal Opioid Withdrawal Syndrome
I. MATERNAL DRUG USE
II. DIAGNOSIS OF DRUG USE IN PREGNANCY
III. NONOPIOID SUBSTANCE EXPOSURE
IV. NEONATAL OPIOID WITHDRAWAL SYNDROME FOLLOWING OPIOID EXPOSURE IN PREGNANCY
V. BREASTFEEDING OF SUBSTANCE-EXPOSED INFANTS
VI. DISCHARGE
VII. LONG-TERM OUTCOMES

13 Initial Care of the Extremely Low Birth Weight Infant
I. INTRODUCTION
II. PRENATAL CONSIDERATIONS
III. DELIVERY ROOM CARE
IV. CARE IN THE INTENSIVE CARE UNIT
V. SUMMARY

14 Developmentally Supportive Care
I. INTRODUCTION
II. ASSESSMENT
III. GOALS OF DEVELOPMENTAL SUPPORT
IV. DEVELOPMENTALLY SUPPORTIVE ENVIRONMENT
V. DEVELOPMENTALLY SUPPORTIVE CARE PRACTICES
VI. PAIN AND STRESS
VII. PARENT SUPPORT/EDUCATION

15 Temperature Control
I. BACKGROUND
II. TEMPERATURE MAINTENANCE
III. MECHANISMS OF HEAT LOSS
IV. THERMONEUTRAL ENVIRONMENT
V. MANAGEMENT TO PREVENT HEAT LOSS
VI. HAZARDS OF TEMPERATURE CONTROL METHODS

16 Follow-up Care of Very Preterm and Very Low Birth Weight Infants
I. INTRODUCTION
II. MEDICAL CARE ISSUES
III. NEURODEVELOPMENTAL OUTCOMES
IV. HIGH-RISK INFANT FOLLOW-UP PROGRAMS

17 Neonatal Transport
I. INTRODUCTION
II. INDICATIONS
III. ORGANIZATION OF TRANSPORT SERVICES
IV. REFERRING HOSPITAL RESPONSIBILITIES
V. TRANSPORT TEAM RESPONSIBILITIES
VI. MEDICAL MANAGEMENT BEFORE TRANSPORT
VII. MEDICAL MANAGEMENT DURING RETURN TRANSPORT
VIII. ARRIVAL AT THE NEONATAL INTENSIVE CARE UNIT
IX. SPECIFIC CONDITIONS AND MANAGEMENT
X. PHYSIOLOGIC CONSIDERATIONS OF AIR TRANSPORTS
XI. SIMULATION IN TRANSPORT MEDICINE

18 Neonatal Intensive Care Unit Discharge Planning
I. INTRODUCTION
II. INFANT’S DISCHARGE READINESS
III. PARENT’S DISCHARGE PREPARATION

19 Decision Making and Ethical Dilemmas
I. BACKGROUND
II. DEVELOPING A PROCESS FOR ETHICAL DECISION MAKING
III. MATERNAL’FETAL ETHICS
IV. EXTREMELY PREMATURE INFANTS
V. THE DECISION TO REDIRECT LIFE-SUSTAINING TREATMENT TO COMFORT MEASURES

20 Management of Neonatal End-of-Life Care and Bereavement Follow-up
I. INTRODUCTION
II. FAMILY-CENTERED END-OF-LIFE CARE PRINCIPLES AND DOMAINS
III. COORDINATION OF CARE
IV. BEREAVEMENT FOLLOW-UP

21 Nutrition
I. INTRODUCTION
II. GROWTH
III. NUTRIENT RECOMMENDATIONS FOR PRETERM INFANTS
IV. SPECIAL CONSIDERATIONS
V. NUTRITIONAL CONSIDERATIONS IN DISCHARGE PLANNING
ACKNOWLEDGMENTS

22 Breastfeeding and Maternal Medications
I. RATIONALE FOR BREASTFEEDING
II. RECOMMENDATIONS ON BREASTFEEDING FOR HEALTHY TERM INFANTS INCLUDE THE FOLLOWING GENERAL PRINCIPLES (CENTERS FOR DISEASE CONTROL AND PREVENTION, AMERICAN ACADEMY OF PEDIATRICS)
III. MANAGEMENT AND SUPPORT ARE NEEDED FOR SUCCESSFUL BREASTFEEDING
IV. MANAGEMENT OF BREASTFEEDING PROBLEMS
V. SPECIAL SITUATIONS
VI. CARE AND HANDLING OF EXPRESSED BREAST MILK
VII. CONTRAINDICATIONS AND CONDITIONS NOT CONTRAINDICATED TO BREASTFEEDING
VIII. MATERNAL MEDICATIONS AND BREASTFEEDING
IX. DETERMINATION OF DRUG SAFETY DURING BREASTFEEDING
X. RESOURCES

23 Fluid and Electrolyte Management
I. DISTRIBUTION OF BODY WATER
II. ASSESSMENT OF FLUID AND ELECTROLYTE STATUS
III. MANAGEMENT OF FLUIDS AND ELECTROLYTES
IV. APPROACH TO DISORDERS OF NA AND WATER BALANCE
V. OLIGURIA
VI. METABOLIC ACID–BASE DISORDERS
VII. DISORDERS OF K BALANCE
VIII. COMMON CLINICAL SITUATIONS

24 Hypoglycemia and Hyperglycemia
I. HYPOGLYCEMIA
II. HYPERGLYCEMIA

25 Abnormalities of Serum Calcium and Magnesium
I. HYPOCALCEMIA
II. HYPERCALCEMIA
III. DISORDERS OF MAGNESIUM: HYPOMAGNESEMIA AND HYPERMAGNESEMIA

26 Neonatal Hyperbilirubinemia
I. BACKGROUND
II. BILIRUBIN METABOLISM
III. NONPATHOLOGIC (BENIGN) HYPERBILIRUBINEMIA
IV. SIGNIFICANT HYPERBILIRUBINEMIA
V. PREVENTION OF HYPERBILIRUBINEMIA IN HEALTHY TERM AND LATE-PRETERM INFANTS
VI. EVALUATION OF INFANTS WITH HYPERBILIRUBINEMIA
VII. FAMILY AND CAREGIVER EDUCATION
VIII. CLINICAL MANAGEMENT
IX. BILIRUBIN NEUROTOXICITY
X. NEONATAL CHOLESTASIS

27 Necrotizing Enterocolitis
I. BACKGROUND
II. DIAGNOSIS
III. MANAGEMENT
IV. PROGNOSIS

28 Neonatal Kidney Conditions
I. RENAL EMBRYOGENESIS AND FUNCTIONAL DEVELOPMENT
II. CLINICAL ASSESSMENT OF THE KIDNEYS AND URINARY TRACT
III. COMMON CLINICAL KIDNEY PROBLEMS IN NEONATES

29 Mechanical Ventilation
I. GENERAL PRINCIPLES
II. NONINVASIVE VENTILATORY SUPPORT
III. INVASIVE MECHANICAL VENTILATORY SUPPORT
IV. INDICATIONS FOR RESPIRATORY SUPPORT
V. HOW VENTILATOR CHANGES AFFECT BLOOD GASES
VI. DISEASE STATES
VII. ADJUNCTS TO MECHANICAL VENTILATION
VIII. COMPLICATIONS AND SEQUELAE

30 Blood Gas and Pulmonary Function Monitoring
I. GENERAL PRINCIPLES
II. OXYGEN USE AND MONITORING
III. ASSESSMENT OF PULMONARY VENTILATION
IV. PULMONARY GRAPHICS MONITORING

31 Apnea
I. BACKGROUND
II. PATHOGENESIS
III. MONITORING AND EVALUATION
IV. TREATMENT
V. DISCHARGE CONSIDERATIONS

32 Transient Tachypnea of the Newborn
I. DEFINITION
II. PATHOPHYSIOLOGY
III. EPIDEMIOLOGY
IV. CLINICAL PRESENTATION
V. DIFFERENTIAL DIAGNOSIS
VI. EVALUATION
VII. MANAGEMENT
VIII. COMPLICATIONS
IX. PROGNOSIS

33 Respiratory Distress Syndrome
I. INTRODUCTION
II. DIAGNOSIS
III. PREVENTION
IV. MANAGEMENT

34 Bronchopulmonary Dysplasia
I. BRONCHOPULMONARY DYSPLASIA (BPD)
II. EPIDEMIOLOGY
III. PATHOGENESIS
IV. THE CLINICAL PRESENTATION
V. EFFORTS TO PREVENT BPD AND MINIMIZE LUNG INJURY
VI. MANAGEMENT OF INFANTS WITH ESTABLISHED BPD
VII. IDENTIFICATION AND TREATMENT OF COMPLICATIONS ASSOCIATED WITH BPD
VIII. DISCHARGE PLANNING
IX. OUTPATIENT THERAPY
X. CHILD AND ADULT OUTCOMES OF BPD

35 Meconium Aspiration
I. BACKGROUND
II. PATHOPHYSIOLOGY
III. PREVENTION OF MECONIUM ASPIRATION SYNDROME
IV. MANAGEMENT OF INFANTS DELIVERED THROUGH MECONIUM-STAINED FLUID
V. MANAGEMENT OF MECONIUM ASPIRATION SYNDROME

36 Persistent Pulmonary Hypertension of the Newborn
I. DEFINITION
II. PHYSIOLOGY AND PATHOGENESIS
III. EPIDEMIOLOGIC ASSOCIATIONS AND RISK FACTORS
IV. CLASSIFICATION
V. DIAGNOSIS
VI. MANAGEMENT
VII. POSTNEONATAL OUTCOMES AMONG INFANTS WITH PPHN

37 Pulmonary Hemorrhage
I. DEFINITION
II. PATHOPHYSIOLOGY
III. EPIDEMIOLOGY
IV. PREDISPOSING FACTORS
V. CLINICAL PRESENTATION
VI. EVALUATION
VII. TREATMENT
VIII. PROGNOSIS

38 Pulmonary Air Leak
I. BACKGROUND
II. TYPES OF AIR LEAKS

39 Extracorporeal Membrane Oxygenation
I. BACKGROUND
II. ECMO CIRCUIT
III. INDICATIONS AND CONTRAINDICATIONS
IV. PHYSIOLOGY
V. MANAGEMENT
VI. SPECIAL SITUATIONS DURING EXTRACORPOREAL MEMBRANE OXYGENATION SUPPORT
VII. COMPLICATIONS
VIII. OUTCOME

40 Shock
I. DEFINITION
II. PATHOPHYSIOLOGY OF NEONATAL SHOCK
III. ETIOLOGY
IV. DIAGNOSIS
V. TREATMENT
VI. TYPICAL CLINICAL SCENARIOS OF SHOCK IN NEONATES

41 Cardiac Disorders
I. INTRODUCTION
II. INCIDENCE AND SURVIVAL
III. TIMING OF PRESENTATION
IV. CLINICAL MANIFESTATIONS OF CONGENITAL HEART DISEASE
V. EVALUATION OF THE NEONATE WITH SUSPECTED CONGENITAL HEART DISEASE
VI. “LESION-SPECIFIC” CARE FOLLOWING ANATOMIC DIAGNOSIS
VII. ACQUIRED HEART DISEASE
VIII. PHARMACOLOGY
IX. ARRHYTHMIAS

42 Blood Products Used in the Newborn
I. WHOLE BLOOD AND BLOOD COMPONENT TRANSFUSIONS
II. PACKED RED BLOOD CELLS
III. FRESH FROZEN PLASMA, THAWED PLASMA
IV. PLATELETS
V. GRANULOCYTES
VI. WHOLE BLOOD
VII. INTRAVENOUS IMMUNOGLOBULIN
VIII. UMBILICAL CORD BLOOD

43 Bleeding
I. ETIOLOGY
II. DIAGNOSTIC WORKUP OF THE BLEEDING NEONATE/INFANT
III. TREATMENT OF NEONATES WITH ABNORMAL COAGULATION LABS WITHOUT CLINICAL BLEEDING
IV. TREATMENT OF BLEEDING

44 Neonatal Thrombosis
I. PHYSIOLOGY
II. EPIDEMIOLOGY AND RISK FACTORS
III. SPECIFIC CLINICAL CONDITIONS
IV. DIAGNOSTIC CONSIDERATIONS
V. MANAGEMENT

45 Anemia
I. HEMATOLOGIC PHYSIOLOGY OF THE NEWBORN
II. ETIOLOGY OF ANEMIA IN THE NEONATE
III. DIAGNOSTIC APPROACH TO ANEMIA IN THE NEWBORN
IV. THERAPY
ACKNOWLEDGMENT

46 Polycythemia
I. DEFINITIONS
II. INCIDENCE
III. CAUSES OF POLYCYTHEMIA
IV. SYMPTOMS
V. SCREENING/DIAGNOSIS
VI. MANAGEMENT
VII. PVET
VIII. OUTCOMES
IX. CONCLUSION

47 Neonatal Thrombocytopenia
I. INTRODUCTION
II. APPROACH TO THE THROMBOCYTOPENIC NEONATE
III. IMMUNE THROMBOCYTOPENIA
IV. PLATELET TRANSFUSIONS IN THE NICU

48 Viral Infections
I. INTRODUCTION
II. CYTOMEGALOVIRUS (CMV) (CONGENITAL, PERIPARTUM, AND POSTNATAL)
III. HERPES SIMPLEX VIRUS (HSV: PERINATAL)
IV. PARVOVIRUS B19 (CONGENITAL)
V. HIV (CONGENITAL AND PERINATAL)
VI. HEPATITIS
VII. VARICELLA-ZOSTER VIRUS (VZV: CONGENITAL OR PERIPARTUM)
VIII. ENTEROVIRUSES (CONGENITAL)
IX. RUBELLA (CONGENITAL)
X. RSV (NEONATAL)
XI. SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (PERINATAL, NEONATAL)
XII. ZIKA VIRUS (ZIKV) (CONGENITAL, PERINATAL, NEONATAL)

49 Bacterial and Fungal Infections
I. BACTERIAL SEPSIS AND MENINGITIS
II. ANAEROBIC BACTERIAL INFECTIONS
III. FUNGAL INFECTIONS
IV. FOCAL BACTERIAL INFECTIONS

50 Congenital Toxoplasmosis
I. EPIDEMIOLOGY
II. PATHOPHYSIOLOGY
III. MATERNAL/FETAL INFECTION
IV. NEONATAL INFECTION
V. OUTCOMES

51 Syphilis
I. INTRODUCTION
II. CLINICAL MANIFESTATIONS
III. EPIDEMIOLOGY
IV. DIAGNOSTIC TESTS FOR SYPHILIS
V. EVALUATION AND TREATMENT OF CONGENITAL SYPHILIS
VI. SCREENING AND TREATMENT OF PREGNANT WOMEN FOR SYPHILIS
VII. FOLLOW-UP ON INFANTS TREATED FOR CONGENITAL SYPHILIS
VIII. INFECTION CONTROL

52 Tuberculosis
I. EPIDEMIOLOGY AND INCIDENCE
II. TRANSMISSION AND PATHOGENESIS
III. MATERNAL TB
IV. TUBERCULOSIS OF THE FETUS OR NEWBORN
V. POSTNATAL TRANSMISSION OF
VI. TREATMENT OF NEONATAL TB DISEASE
VII. MANAGEMENT OF AN EXPOSED NEONATE
VIII. BCG

53 Lyme Disease
I. LYME DISEASE
II. DIAGNOSIS
III. TREATMENT OF MOTHERS AND THE NEWBORN

54 Intracranial Hemorrhage and White Matter Injury/Periventricular Leukomalacia
OVERVIEW
I. SUBDURAL HEMORRHAGE AND EPIDURAL HEMORRHAGE
II. SUBARACHNOID HEMORRHAGE
III. INTRAPARENCHYMAL HEMORRHAGE
IV. GERMINAL MATRIX HEMORRHAGE/INTRAVENTRICULAR HEMORRHAGE
V. WHITE MATTER INJURY/PERIVENTRICULAR LEUKOMALACIA

55 Perinatal Asphyxia and Hypoxic-Ischemic Encephalopathy
I. PERINATAL ASPHYXIA
II. INCIDENCE
III. ETIOLOGY
IV. PATHOPHYSIOLOGY
V. DIAGNOSIS
VI. NEUROLOGIC SIGNS
VII. MULTIORGAN DYSFUNCTION
VIII. LABORATORY EVALUATION OF ASPHYXIA
IX. BRAIN IMAGING
X. EEG
XI. PATHOLOGIC FINDINGS OF BRAIN INJURY
XII. TREATMENT
XIII. NEUROPROTECTIVE STRATEGIES
XIV. OUTCOME IN PERINATAL ASPHYXIA

56 Neonatal Seizures
I. INTRODUCTION
II. DIAGNOSIS
III. ETIOLOGY
IV. INVESTIGATIONS
V. TREATMENT
VI. PROGNOSIS

57 Neural Tube Defects
I. DEFINITIONS AND PATHOLOGY
II. DIAGNOSIS
III. EVALUATION
IV. CONSULTATION
V. MANAGEMENT
VI. PROGNOSIS

58 Orthopedic Problems
I. INTRODUCTION
II. CONGENITAL MUSCULAR TORTICOLLIS
III. POLYDACTYLY
IV. ORTHOPEDIC BIRTH INJURIES
V. CONGENITAL AND INFANTILE SCOLIOSIS
VI. DEVELOPMENTAL DISLOCATION OF THE HIP
VII. GENU RECURVATUM
VIII. DEFORMITIES OF THE FEET
IX. COMPARTMENT SYNDROME OF THE NEWBORN

59 Osteopenia (Metabolic Bone Disease) of Prematurity
I. GENERAL PRINCIPLES
II. DIAGNOSIS
III. TREATMENT

60 Inborn Errors of Metabolism
I. INTRODUCTION
II. CLINICAL PRESENTATION
III. EVALUATION AND MANAGEMENT
IV. IEMs WITH METABOLIC ACIDOSIS
V. IEMs WITH HYPERAMMONEMIA
VI. IEMs WITH HYPOGLYCEMIA
VII. IEMs WITH NEONATAL SEIZURES
VIII. IEMs WITH HYPOTONIA
IX. IEMs WITH LIVER DYSFUNCTION
X. INBORN ERROR OF METABOLISM WITH CARDIOMYOPATHY
XI. POSTMORTEM DIAGNOSIS
XII. ROUTINE NEWBORN SCREENING
ACKNOWLEDGMENTS

61 Thyroid Disorders
I. THYROID PHYSIOLOGY IN PREGNANCY
II. MATERNAL HYPERTHYROIDISM
III. MATERNAL HYPOTHYROIDISM
IV. FETAL AND NEONATAL GOITER
V. THYROID PHYSIOLOGY IN THE FETUS AND NEWBORN
VI. CONGENITAL HYPOTHYROIDISM
VII. NEONATAL HYPERTHYROIDISM
VIII. MATERNAL THYROID MEDICATIONS AND BREASTFEEDING

62 Neonatal Effects of Maternal Diabetes
I. BACKGROUND
II. CLASSIFICATION OF DIABETES IN PREGNANCY
III. MATERNAL MANAGEMENT AND DELIVERY
IV. FETAL AND NEONATAL EFFECTS OF MATERNAL DIABETES MELLITUS
V. NEONATAL MANAGEMENT OF IDMS
VI. LONG-TERM EFFECTS

63 Differences of Sex Development
I. DEFINITION AND NOMENCLATURE
II. IMMEDIATE POSTNATAL CONSIDERATIONS PRIOR TO SEX DESIGNATION
III. TYPICAL SEX DEVELOPMENT
IV. NURSERY EVALUATION OF A NEWBORN WITH A SUSPECTED DIFFERENCE OF SEX DEVELOPMENT
V. GONADAL DIFFERENTIATION DISORDERS
VI. OTHER XX DSD
VII. OTHER XY DSD
VIII. ISSUES OF SEX/GENDER DESIGNATION

64 Surgical Conditions in the Newborn
I. PRENATAL FINDINGS ASSOCIATED WITH SURGICAL DISEASE
II. POTENTIAL PRENATAL INTERVENTIONS TO AVOID POSTNATAL SURGICAL EMERGENCIES
III. POSTNATAL SURGICAL DISORDERS: DIAGNOSIS BY PRESENTING SYMPTOM
IV. LESIONS CAUSING RESPIRATORY DISTRESS
V. LESIONS CAUSING INTESTINAL OBSTRUCTION
VI. OTHER GASTROINTESTINAL SURGICAL CONDITIONS
VII. RENAL DISORDERS
VIII. TUMORS
IX. ABDOMINAL MASSES
X. INGUINAL HERNIAS
XI. SCROTAL SWELLING
XII. NEUROSURGICAL CONDITIONS
XIII. COMMON TESTS USED IN THE DIAGNOSIS OF SURGICAL CONDITIONS
XIV. GENERAL PREOPERATIVE MANAGEMENT
XV. GENERAL INTRAOPERATIVE MANAGEMENT

65 Skin Care and Conditions
I. INTRODUCTION
II. ANATOMY
III. SKIN CARE PRACTICES
IV. WOUND CARE
V. IV EXTRAVASATION
VI. COMMON SKIN LESIONS
VII. VASCULAR ABNORMALITIES
VIII. PIGMENTATION ABNORMALITIES
IX. DEVELOPMENTAL ABNORMALITIES OF THE SKIN
X. OTHER SKIN DISORDERS

66 Vascular Anomalies
I. INTRODUCTION
II. VASCULAR TUMORS
III. VASCULAR MALFORMATIONS
ACKNOWLEDGMENTS

67 Retinopathy of Prematurity
GENERAL PRINCIPLES
I. DEFINITION
II. PATHOGENESIS
III. DIAGNOSIS
IV. CLASSIFICATION AND DEFINITIONS
V. TIMING OF TREATMENT
VI. PROGNOSIS
VII. PREVENTION
VIII. TREATMENT

68 Hearing Health in Neonatal Intensive Care Unit Graduates
GENERAL PRINCIPLES
I. DEFINITION
II. INCIDENCE
III. ETIOLOGY
IV. SCREENING TESTS
V. FOLLOW-UP TESTING
VI. MEDICAL EVALUATION
VII. INTERVENTIONS FOR OPTIMIZING LANGUAGE DEVELOPMENT
VIII. OUTCOMES

69 Neonatal Procedures: Basic Principles and Considerations
I. INTRODUCTION
II. GENERAL PRINCIPLES
III. BLOOD DRAWING
IV. VASCULAR CATHETERIZATION
V. BLADDER CATHETERIZATION
VI. LUMBAR PUNCTURE
VII. INTUBATION
VIII. THORACENTESIS AND CHEST TUBE PLACEMENT
IX. ABDOMINAL PARACENTESIS FOR REMOVAL OF ASCITIC FLUID
X. PERICARDIOCENTESIS

70 Preventing and Treating Pain and Stress Among Infants in the Newborn Intensive Care Unit
I. BACKGROUND
II. RECOMMENDATIONS ON PREVENTION AND MANAGEMENT OF PROCEDURAL PAIN IN THE NEONATE FROM THE COMMITTEE ON FETUS AND NEWBORN AND SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE OF THE AMERICAN ACADEMY OF PEDIATRICS (AAP)
III. EVALUATING NEONATAL PAIN AND STRESS
IV. MANAGEMENT: PAIN PREVENTION AND TREATMENT
V. PHARMACOLOGIC TREATMENT OF PROCEDURE-RELATED PAIN
VI. CONCLUSION

71 Racial Disparities in the Neonatal Intensive Care Unit
I. BACKGROUND
II. DISPARITIES IN CAUSES OF INFANT MORTALITY
III. CAUSES OF RACIAL DISPARITIES IN PRETERM BIRTH
IV. RACIAL DISPARITIES IN THE NICU
V. RECOMMENDATIONS

72 Patient Safety and Quality Improvement
I. PATIENT SAFETY
II. QUALITY IMPROVEMENT
III. QUALITY DASHBOARDS
IV. DEVELOPING A QUALITY AND SAFETY INFRASTRUCTURE
Appendix A: Neonatal Emergency Drug Dosing Guide
Appendix B: Intubation Sedation Guidelines

Index

이 책의 특징

Practical, informative, and easy to read, Cloherty and Stark’s Manual of Neonatal Care, 9th Edition, offers an up-to-date approach to the diagnosis and medical management of routine and complex conditions encountered in the newborn. Written by expert authors from major neonatology programs across the U.S. and edited by Drs. Eric C. Eichenwald, Anne R. Hansen, Camilia R. Martin, and Ann R. Stark, this popular manual has been fully updated to reflect recent advances in the field, providing NICU physicians, neonatal-perinatal fellows, residents, and neonatal nurse practitioners with quick access to key clinical information.

Provides essential, detailed information on the evaluation and management of common and unusual neonatal conditions, with extensive updates from cover to cover.

Includes new information on multiple topics, including genetics, respiratory management, infectious diseases, and neonatal jaundice, with 2 new chapters on quality improvement and safety in the NICU, and racial disparities in neonatal care.

Uses an easy-access outline format and numerous tables to help you find what you need quickly.

Features extensive family support content, with chapters on breastfeeding, developmentally supportive care, bereavement, and decision-making and ethical dilemmas.

Contains appendices on neonatal emergency drug dosing and intubation sedation guidelines for fast reference.
Enrich Your eBook Reading Experience

Read directly on your preferred device(s), such as computer, tablet, or smartphone.

Easily convert to audiobook, powering your content with natural language text-to-speech.